{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:20:03Z","timestamp":1772828403157,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["MH097488"],"award-info":[{"award-number":["MH097488"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["U01MH090325"],"award-info":[{"award-number":["U01MH090325"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Changes in tryptophan metabolism affect human physiology including the immune system, mood, and sleep and are associated with human immunodeficiency virus (HIV) pathogenesis. This study investigates whether the treatment of HIV-infected individuals with the neurokinin-1 receptor antagonist, aprepitant, alters tryptophan metabolism.<\/jats:p>\n            <jats:p>This study utilized archival samples from 3 phase 1B clinical trials \u201cAnti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 Antagonist Aprepitant\u201d-2 double-blinded, placebo-controlled, and 1 open-label study. We tested samples from a total of 57 individuals: 26 combination antiretroviral therapy (cART) na\u00efve individuals receiving aprepitant, 19 cART na\u00efve individuals receiving placebo, and 12 individuals on a ritonavir-containing cART regimen receiving aprepitant. We evaluated the effect of aprepitant on tryptophan metabolism by measuring levels of kynurenine and tryptophan in archival plasma samples and calculating the kynurenine to tryptophan ratio.<\/jats:p>\n            <jats:p>Aprepitant treatment affected tryptophan metabolism in both cART treated and cART na\u00efve individuals with more profound effects in patients receiving cART. While aprepitant treatment affected tryptophan metabolism in all HIV-infected patients, it only significantly decreased kynurenine to tryptophan ratio in cART treated individuals. Aprepitant treatment offers an opportunity to target inflammation and mood disorders frequently co-existing in chronic HIV infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025313","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T15:09:33Z","timestamp":1623424173000},"page":"e25313","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART na\u00efve adults living with HIV"],"prefix":"10.1097","volume":"100","author":[{"given":"Sergei","family":"Spitsin","sequence":"first","affiliation":[{"name":"Children's Hospital of Philadelphia Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Pappa","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Kinder","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight L.","family":"Evans","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Rappaport","sequence":"additional","affiliation":[{"name":"Tulane National Primate Research Center, Covington, LA, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-3603","authenticated-orcid":false,"given":"Steven D.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia Research Institute"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","article-title":"Immune suppression and immune activation in depression","volume":"25","author":"Blume","year":"2011","journal-title":"Brain Behav Immun"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"32ra36","DOI":"10.1126\/scitranslmed.3000632","article-title":"Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease","volume":"2","author":"Favre","year":"2010","journal-title":"Sci Transl Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","article-title":"Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients","volume":"44","author":"Huengsberg","year":"1998","journal-title":"Clin Chem"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/QAD.0000000000001124","article-title":"Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans","volume":"30","author":"Lee","year":"2016","journal-title":"AIDS"},{"key":"R5-20250504","article-title":"Clinical relevance of kynurenine pathway in HIV\/AIDS: an immune checkpoint at the crossroads of metabolism and inflammation","volume":"17","author":"Routy","year":"2015","journal-title":"AIDS Rev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archpsyc.1994.03950110025005","article-title":"Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients","volume":"51","author":"Delgado","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMra050730","article-title":"The medical management of depression","volume":"353","author":"Mann","year":"2005","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2005.05.001","article-title":"Mood disorders in the medically ill: scientific review and recommendations","volume":"58","author":"Evans","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archpsyc.1989.01810010083011","article-title":"Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization","volume":"46","author":"Schleifer","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"R11-20250504","first-page":"319","article-title":"Immune correlates of stress and depression","volume":"25","author":"Evans","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mpr.26","article-title":"Improving methods of assessing natural killer cell cytotoxicity","volume":"15","author":"Sephton","year":"2006","journal-title":"Int J Methods Psychiatr Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.281.24.2268","article-title":"Stress-induced immunomodulation: implications for infectious diseases?","volume":"281","author":"Glaser","year":"1999","journal-title":"JAMA"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-3999(02)00309-4","article-title":"Depression and immune function: central pathways to morbidity and mortality","volume":"53","author":"Kiecolt-Glaser","year":"2002","journal-title":"J Psychosom Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/scnp.2001.0060277","article-title":"The neuroimmunology of stress and depression","volume":"6","author":"Raison","year":"2001","journal-title":"Semin Clin Neuropsychiatry"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/PSY.0b013e318177216c","article-title":"Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence","volume":"70","author":"Ironson","year":"2008","journal-title":"Psychosom Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.1993.03510210054027","article-title":"Depressive symptoms and CD4 lymphocyte decline among HIV-infected men","volume":"270","author":"Burack","year":"1993","journal-title":"JAMA"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1176\/appi.ajp.159.10.1752","article-title":"Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection","volume":"159","author":"Evans","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.285.11.1466","article-title":"Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study","volume":"285","author":"Ickovics","year":"2001","journal-title":"JAMA"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.153.11.1430","article-title":"Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study","volume":"153","author":"Lyketsos","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1996.00440180095012","article-title":"Depressive affect and survival among gay and bisexual men infected with HIV","volume":"156","author":"Mayne","year":"1996","journal-title":"Arch Intern Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1047-2797(96)00064-6","article-title":"Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey","volume":"6","author":"Page-Shafer","year":"1996","journal-title":"Ann Epidemiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PSY.0b013e3181777a5f","article-title":"Role of depression, stress, and trauma in HIV disease progression","volume":"70","author":"Leserman","year":"2008","journal-title":"Psychosom Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PSY.0b013e318177354f","article-title":"Coping as a multisystem construct associated with pathways mediating HIV-relevant immune function and disease progression","volume":"70","author":"Temoshok","year":"2008","journal-title":"Psychosom Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF02903937","article-title":"Relationship of psychosocial factors to HIV disease progression","volume":"18","author":"Patterson","year":"1996","journal-title":"Ann Behav Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0008-8749(90)90125-B","article-title":"Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T\/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors","volume":"127","author":"Hellstrand","year":"1990","journal-title":"Cell Immunol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4049\/jimmunol.139.3.869","article-title":"Role of serotonin in the regulation of human natural killer cell cytotoxicity","volume":"139","author":"Hellstrand","year":"1987","journal-title":"J Immunol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.153.2.489","article-title":"Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo","volume":"153","author":"Aune","year":"1994","journal-title":"J Immunol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.biopsych.2007.08.012","article-title":"Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus\/acquired immunodeficiency syndrome","volume":"63","author":"Evans","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PSY.0b013e3181f883ce","article-title":"Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication","volume":"72","author":"Benton","year":"2010","journal-title":"Psychosom Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biopsych.2015.11.003","article-title":"The selective serotonin reuptake inhibitor citalopram decreases human immunodeficiency virus receptor and coreceptor expression in immune cells","volume":"80","author":"Greeson","year":"2016","journal-title":"Biol Psychiatry"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"e95893","DOI":"10.1172\/jci.insight.95893","article-title":"Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults","volume":"2","author":"Spitsin","year":"2017","journal-title":"JCI Insight"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/QAD.0000000000000638","article-title":"Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults","volume":"29","author":"Tebas","year":"2015","journal-title":"AIDS"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"e24180","DOI":"10.1371\/journal.pone.0024180","article-title":"A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults","volume":"6","author":"Tebas","year":"2011","journal-title":"PLoS One"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"04","DOI":"10.1016\/j.biopsych.2016.04.019","article-title":"Inflammasome activation in major depressive disorder: a pivotal linkage between psychological stress, purinergic signaling, and the kynurenine pathway","volume":"80","author":"Velasquez","year":"2016","journal-title":"Biol Psychiatr"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12967-016-0904-y","article-title":"Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV","volume":"14","author":"Barrett","year":"2016","journal-title":"J Transl Med"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.5665\/sleep.3208","article-title":"Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia","volume":"36","author":"Ratti","year":"2013","journal-title":"Sleep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:36:50Z","timestamp":1746337010000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":37,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025313","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2020-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}